Prescribe a new clinical evaluation in a month.

The doctor reassures that the patient is being adequately anticoagulized and prescribe a new clinical evaluation in a month. Although

CTEPH is a potentially curable form of pulmonary hypertension, persistent or recurrent PH post PEA may complicate the clinical curse

of the disease. Patients remaining strongly symptomatic after PEA, should be further evaluated for recurrent/persistent disease. If left

without further evaluation, the patient runs the risk of further deterioration.  

This is a wrong response that could lead to potentially harmful results to the health.